Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study.
D000792:Angiography; D005260:Female; D005340:Fibrinogen / Q000097:blood; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications; D006400:Hematocrit; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000097:blood; D011651:Pulmonary Artery / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011877:Radionuclide Imaging; D012712:Serum Globulins / Q000032:analysis; D013997:Time Factors
D005343:Fibrinolytic Agents; D012712:Serum Globulins; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin